Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001561736-26-000002

Options or other derivatives

  • Director acquired 52,796 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Clark Kenneth A · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Grant or award : show line 1 in the form Stock Option (right to buy) +35,000 35,000 D
2026-01-02 Grant or award : show line 2 in the form Stock Option (right to buy) +17,796 $8.76 $155,893 17,796 D
Loading xslF345X05/wk-form4_1767742986.xml…